| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-115 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2015-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107106629-B |
| titleOfInvention |
Therapy for treating tumors, acquired immunodeficiency syndrome and leukemia by dual immunobiostimulation |
| abstract |
The present invention relates to a composition for use as a tumour therapy, an acquired immunodeficiency syndrome therapy and a leukemia therapy in humans and animals. The composition of the invention for use as an anti-tumor agent for humans and animals consists of a mixture comprising or preferably consisting of: lactobacillus reuteri LRE03DSM 23879 bacterial strain capable of strongly stimulating the production of proinflammatory cytokine (Th1) interferon INF- γ, said cytokine showing a significant anti-tumor activity, and/or lactobacillus salivarius LS06DSM 26037 bacterial strain capable of strongly stimulating the production of dendritic cells, said dendritic cells also showing a significant anti-tumor activity. |
| priorityDate |
2014-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |